Chiral Technologies, Inc. is a subsidiary of Daicel Corporation, the global market leader in enantioselective chromatography, offering the most extensive portfolio of chiral stationary phases available on the market. Enantioselective chromatography is essential to accelerate drug discovery and development processes. Scientists in the pharmaceutical, agricultural and food industries, universities, and government agencies rely on our expertise in enantioselective chromatography to separate chiral molecules into single enantiomers in research and development departments, and QC laboratories to initiate pre-clinical trials.
Chiral Technologies serves the North and Latin American markets through Chiral Technologies Inc. (West Chester, Pa.), the European market through Chiral Technologies Europe SAS (Illkirch, France), and the Asian market through Daicel Chiral Technologies India and Daicel Chiral Technologies China, all wholly owned subsidiaries of Daicel Corporation.
Daicel chiral columns:
Chiral Technologies' headquarters, including a state-of-the-art technical center, are located in West Chester, PA.
800 North Five Points Road
West Chester, PA 19380
TELEPHONE
(610) 594-2100
or 800 6CHIRAL
FAX
(610) 594-2325
WEB SITE
NUMBER OF EMPLOYEES
22
YEAR FOUNDED
1990
Targeted Blood Lipidomics of Colorectal Cancer: An HTC-18 Interview with Jef Focant
July 26th 2024At HTC-18 in Leuven, Executive Editor of LCGC International, Alasdair Matheson, spoke to Jef Focant from the University of Liege about his talk entitled, “Targeted Blood Lipidomics of Colorectal Cancer."
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.